The gastrointestinal stromal tumor (GIST) market is estimated to be valued at USD 1.2 Bn in 2024 and is expected to reach USD 2.28 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.6% from 2024 to 2031. https://www.writerscafe.org/kirtitawale/blogs/The-Gastrointestinal-Stromal-Tumor-Market-is-Anticipated-to-Witness-High-Growth-Owing-to-Increasing-Incidence-of-Stomach-Cancer/246695/